Accuray (ARAY) Reports Breakeven Q4 EPS; Guides FY09 Sales
More News related to ARAY
- Accuray Receives Prestigious Awards for 2008 Advertising Campaign
- Accuray Incorporated's CEO to Speak at 27th Annual JP Morgan Healthcare Conference
- Accuray Incorporated to Present at 11th Annual Needham Growth Stock Conference
- Accuray Reaches 100th U.S. CyberKnife System Installation
- Accuray (ARAY) Reports Q1 Earnings
More News related to Earnings
- Standard & Poor's Lowers Ratings on PNC Financial (PNC)
- DA Davidson Downgrades Cascade (CAE) to Underperform
- BMO Downgrades F5 Networks (FFIV) to Market Perform
- Sterne Agee Downgrades EZCorp (EZPW) to Neutral
- CL King Downgrades Steven Madden (SHOO) to Neutral
Accuray Incorporated (Nasdaq: ARAY) reports Q4 EPS of $0.00, 4 cents lower than the analyst estimate of $0.04. Revenues for the quarter were $50.9 million, versus the consensus of $56.10 million.
Sees FY09 sales in the range of $230-$250 million, versus the consensus of $240.11 million.
Accuray Incorporated designs, develops, and sells the CyberKnife system, an image-guided robotic radio surgery system for the treatment of solid tumors.
Related Categories
EarningsGuidance
Hot List
Stocks Mentioned
-0.25Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
